Lyell Immunopharma, Inc. - LYEL
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| 4 | 13 |
| 8-K | 5 |
| SCHEDULE 13G/A | 3 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | — | 0001012975-26-000439 | View |
| May 11, 2026 | SCHEDULE 13G/A | — | 0001193125-26-216076 | View |
| May 08, 2026 | SCHEDULE 13G/A | — | 0001168404-26-000021 | View |
| May 06, 2026 | 8-K | May 06, 2026 | 0001628280-26-031269 | View |
| Apr 21, 2026 | SCHEDULE 13G | — | 0001193125-26-165277 | View |
| Mar 16, 2026 | 4 | Mar 09, 2026 | 0001808821-26-000006 | View |
| Mar 12, 2026 | 8-K | Mar 12, 2026 | 0001628280-26-017244 | View |
| Mar 09, 2026 | 4 | Mar 06, 2026 | 0001012975-26-000234 | View |
| Mar 09, 2026 | 4 | Mar 06, 2026 | 0001012975-26-000235 | View |
| Mar 09, 2026 | 8-K | Mar 06, 2026 | 0001193125-26-097615 | View |
| Feb 12, 2026 | 4 | Feb 11, 2026 | 0001907345-26-000002 | View |
| Feb 12, 2026 | 4 | Feb 11, 2026 | 0001866154-26-000002 | View |
| Feb 12, 2026 | 4 | Feb 11, 2026 | 0001327111-26-000002 | View |
| Feb 11, 2026 | 4 | Feb 10, 2026 | 0001959742-26-000001 | View |
| Feb 11, 2026 | 4 | Feb 10, 2026 | 0002095702-26-000002 | View |
| Feb 11, 2026 | 4 | Feb 10, 2026 | 0001771329-26-000001 | View |
| Feb 11, 2026 | 4 | Feb 09, 2026 | 0001327111-26-000001 | View |
| Feb 11, 2026 | 4 | Feb 09, 2026 | 0001907345-26-000001 | View |
| Feb 11, 2026 | 4 | Feb 09, 2026 | 0001866154-26-000001 | View |
| Jan 06, 2026 | 4 | Dec 24, 2025 | 0002095702-26-000001 | View |
| Dec 08, 2025 | 8-K | Dec 07, 2025 | 0001193125-25-310469 | View |
| Dec 05, 2025 | 8-K | Dec 03, 2025 | 0001193125-25-309621 | View |